Adrenergic Blockers Interactions

Synergistic effect expected when similar neuromuscular blocking agents are given concurrently with galantamine.

Source: NLP:galantamine

Synergistic effect expected when similar neuromuscular blocking agents given concurrently with galantamine.

Source: NLP:galantamine hydrobromide

Excessive neuromuscular blockade may occur; concomitant use requires caution.

Source: NLP:magnesium sulfate

Increase the pressor effect of phenylephrine hydrochloride.

Source: NLP:phenylephrine hci

Increase the pressor effect of phenylephrine hydrochloride.

Source: NLP:phenylephrine hydrochloride

Concomitant administration associated with increased risk of serious infections and neutropenia. Not recommended.

Source: NLP:rilonacept

Concurrent use may cause prolonged respiratory paralysis. Can be reversed by calcium salts but mechanical assistance may be necessary.

Source: NLP:tobramycin sulfate

Concomitant use may result in exaggerated hypotensive response. In rare instances with severe cardiomyopathy or recent MI, serious adverse effects have occurred.

Source: NLP:verapamil hydrochloride

Amphetamines inhibit the effects of adrenergic blockers.

Source: NLP:amphetamine sulfate

Chlorthalidone potentiates the action of ganglionic peripheral adrenergic blocking drugs, increasing antihypertensive effects.

Source: NLP:chlorthalidone

Clindamycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents; use with caution in patients receiving such agents.

Source: NLP:clindamycin hydrochloride

Clindamycin has neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; use with caution in patients receiving such agents.

Source: NLP:clindamycin in 5 percent dextrose

Clindamycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents; use with caution.

Source: NLP:clindamycin palmitate hydrochloride

Clindamycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents. Use with caution in patients receiving such agents.

Source: NLP:clindamycin phosphate

Clindamycin may enhance the action of neuromuscular blocking agents due to its neuromuscular blocking properties. Use with caution in patients receiving such agents.

Source: NLP:clindamycin phosphate usp, 1%

Clindamycin has neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Use with caution in patients receiving such agents.

Source: NLP:clindamycin phosphate, benzoyl peroxide

Clindamycin has neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Use with caution in patients receiving such agents.

Source: NLP:clindamycin phosphate and tretinoin

Clindamycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents. Use with caution in patients receiving such agents.

Source: NLP:clindamycin phosphate gel usp, 1%

Adrenergic blockers are inhibited by amphetamines, potentially reducing their therapeutic effect.

Source: NLP:dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate

Amphetamines inhibit the effects of adrenergic blockers.

Source: NLP:dextroamphetamine sulfate

Dobutamine may be ineffective if patient recently received β-blocking drugs; peripheral vascular resistance may increase.

Source: NLP:dobutamine

Potentiation of adrenergic blocking effects occurs with concurrent use.

Source: NLP:furosemide

Lincomycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents; use with caution in patients receiving such agents.

Source: NLP:lincomycin

Lincomycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents; use with caution in patients receiving such agents.

Source: NLP:lincomycin hydrochloride

Electrolyte imbalances from mannitol may result in cardiac adverse reactions; monitor serum electrolytes and discontinue if cardiac status worsens.

Source: NLP:mannitol

Hyperthyroidism increases clearance of beta blockers; dose reduction may be needed when hyperthyroid patient becomes euthyroid with methimazole treatment.

Source: NLP:methimazole

Niacin may potentiate the effects of ganglionic blocking agents, resulting in postural hypotension.

Source: NLP:niacin

Phentermine may decrease the hypotensive effect of these agents.

Source: NLP:phentermine hydrochloride

Hypotensive effect of sodium nitroprusside is augmented by ganglionic blocking agents.

Source: NLP:sodium nitroprusside

May increase the effect of vasopressin on mean arterial blood pressure. Hemodynamic monitoring recommended.

Source: NLP:vasopressin

May increase vasopressin effect on mean arterial blood pressure. Hemodynamic monitoring recommended; adjust vasopressin dose as needed.

Source: NLP:vasopressin in 0.9% sodium chloride